Overview

Vilon is a synthetic dipeptide (Lys-Glu) bioregulator developed by Professor Vladimir Khavinson from amino acid analysis of Thymalin, a natural thymus extract with immunomodulatory properties. It is one of the simplest bioactive peptides known, yet demonstrates measurable effects on immune cell proliferation, gene expression via chromatin remodeling, potential lifespan extension in animal models, and anti-inflammatory cytokine regulation. Its mechanism involves selective deheterochromatinization — epigenetic activation of silenced gene regions in aging cells.

Mechanism of Action

Vilon causes progressive activation (deheterochromatinization) of facultative heterochromatin in aging cells, selectively reactivating silenced genes by loosening chromatin structure without disturbing structural heterochromatin. It interacts with the CHUK gene encoding a component of the NF-κB signaling pathway, modulating cytokine production and immune cell activation at a fundamental regulatory level. Specifically, it stimulates T-cell precursor (thymocyte) proliferation and maturation, increases CD4 and CD5 expression on thymic cells, increases argyrophilic protein expression in cell nuclei, and reduces inflammatory cytokine synthesis by up to 6-fold.

Potential Benefits

  • T-cell maturation and proliferation support
  • CD4+ and CD5+ expression enhancement
  • Up to 6-fold reduction in inflammatory cytokine synthesis
  • Epigenetic activation of silenced gene regions in aging cells
  • Thymic recovery after gamma radiation in animal models
  • NF-κB pathway modulation balancing immune activation and inflammation
  • Potential type 1 diabetes autoimmune modulation

Research Dosage Notes

The following reflects doses used in published research studies. This is not medical advice.

Russian clinical context: typically 1-2 mcg/kg subcutaneously. Oral capsule forms: 10 mg/day in 30-day cycles. Start with short courses.

Amino Acid Sequence

Lys-Glu (KE)

Side Effects & Safety

  • Well-tolerated in available studies
  • Minimal adverse effects reported

Synergistic Compounds

The following compounds have been studied alongside Vilon for potential complementary or synergistic effects:

Learn More

References & Further Reading

  • [object Object]
  • [object Object]
  • [object Object]